The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.
Open accessAbstract
To further our understanding of the functional role of catecholaminergic systems in regulating hypothalamic corticotropin-releasing hormone (CRH) secretion, we assessed the direct effects of a multiplicity of catecholamine agonists and antagonists on hypothalamic CRH secretion. To accomplish this, we used an in vitro rat hypothalamic organ culture system in which CRH secretion from single explants was evaluated by a specific RIA (IR-rCRH). Norepinephrine (NE) stimulated IR-rCRH secretion dose dependently, with peak effects in the nanomolar range. The effect of NE was antagonized by the mixed alpha antagonist phentolamine, the alpha 1 antagonist prazosin, and the alpha 2 antagonist yohimbine, but not by the beta blocker, L-propanolol. Compatible with these data were the findings that the alpha 1 agonist phenylephrine and the alpha 2 agonist clonidine both stimulated IR-rCRH secretion in a dose-dependent fashion. On the other hand, whereas the beta agonist, isoproterenol, caused a weak, non-dose-dependent increase in IR-rCRH secretion, this effect could not be antagonized by L-propanolol. Despite pretreatment with serotonin and acetylcholine antagonists, the effect of NE upon IR-rCRH secretion was undiminished, suggesting that NE-induced CRH secretion is not mediated by either neurotransmitter. On the other hand, pretreatment with gamma-aminobutyric acid (GABA) attenuated NE-induced IR-rCRH secretion. Whereas epinephrine (E) stimulated IR-rCRH secretion, this occurred only at higher concentrations, and was antagonized by phentolamine, but not by L-propanolol. Dopamine (DA) had a weak stimulatory effect that could be antagonized by the DA1 receptor antagonist, SCH 23390, but not by phentolamine. We conclude that NE and E stimulate hypothalamic IR-rCRH secretion via alpha 1 and alpha 2 receptors. The effect of NE upon IR-rCRH secretion is not apparently mediated by serotonergic or cholinergic interneurons, but is modulated by the inhibitory neurotransmitter, GABA. These data support the idea that the central catecholaminergic systems are excitatory rather than inhibitory upon CRH secretion when acting directly at the hypothalamic level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurotransmitters regulate peripheral cytokines through cortisol levels. For example, acetylcholine (Ach), dopamine (DA), and noradrenaline (NA) promote the secretion of corticotropin-releasing hormone (CRH) in the hypothalamus, and serotonin (5-HT) inhibits the secretion of CRH in the hypothalamus and adrenocorticotropic hormone (ACTH) in the pituitary[7].”
From Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? (2016) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baltosser, W. H., & Zar, J. H. (1996) · Ecology · doi:10.2307/2265725 · Cited by 35,166
Multiple Range and Multiple F Tests
Duncan, D. B. (1955) · Biometrics · doi:10.2307/3001478 · Cited by 23,446
THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
Greenwood, F. C., Hunter, W., & GLOVER, J. S. (1963) · Biochemical Journal · doi:10.1042/bj0890114 · Cited by 10,141
Zar, J. H. (1996) · Cited by 7,837
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
Stress hormones: their interaction and regulation
Axelrod, J., & Reisine, T. D. (1984) · Science · doi:10.1126/science.6143403 · Cited by 1,527
Lindvall, O., & Björklund, A. (1974) · PubMed · Cited by 1,131
Clinical and Biochemical Manifestations of Depression
Gold, P. W., Goodwin, F. K., & Chrousos, G. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190706 · Cited by 1,057
Self-citationSvensson, T. H., Bunney, B. S., & Aghajanian, G. K. (1975) · Brain Research · doi:10.1016/0006-8993(75)90276-0 · Cited by 1,015
Antoni, F. A. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-351 · Cited by 888
Cited by
Sorted by citations
Items 101–187 of 187
Crossroads of corticotropin releasing hormone, corticosteroids and monoamines
van Praag, H. M. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000022115 · Cited by 29
Shibasaki, T., Tsumori, C., Hotta, M., Imaki, T., Yamada, K., & Demura, H. (1995) · Brain Research · doi:10.1016/0006-8993(94)01306-3 · Cited by 29
Alexander, S. L., & IRVINE, C. H. G. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00542.x · Cited by 28
Basic and Clinical Studies with Corticotropin-Releasing Hormone
Gold, P. W., Pigott, T. A., Kling, M. A., Kalogeras, K. T., & Chrousos, G. P. (1988) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30500-8 · Cited by 29
Self-citationFeldman, S., & Weidenfeld, J. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90004-d · Cited by 26
The Regulation of Hypothalamic Corticotropin‐Releasing Factor Release: In Vitro Studies
Grossman, A. B., Costa, A. C., Navarra, P., & Tsagarakis, S. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514368.ch7 · Cited by 26
Endocrinological effects of mirtazapine in healthy volunteers
Schüle, C., Baghai, T. C., Bidlingmaier, M., Strasburger, C. J., & Laakmann, G. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00264-6 · Cited by 25
“stimulate the secretion of corticotropin releasing hormone (CRH) and vasopressin (Hiwatari and Johnston, 1985; Plotsky, 1987; Szafarczyk et al., 1987; Calogero et al., 1988; Hillhouse and Milton, 1989).”
BackgroundMechanisms of Stress on Reproduction: Evidence for a Complex Intra-Hypothalamic Circuit
Calogero, A. E., Bagdy, G., & D’Agata, R. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09010.x · Cited by 25
Self-citationTataranni, P. A., Cizza, G., Snitker, S., Gucciardo, F., Lotsikas, A. J., Chrousos, G. P., & Ravussin, É. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90092-6 · Cited by 25
Self-citationBagdy, G., Calogero, A. E., Szemeredi, K., Chrousos, G. P., & Gold, P. W. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90111-9 · Cited by 25
Self-citationPalego, L., Giannaccini, G., & Betti, L. (2020) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524920999201214231243 · Cited by 25
Studies on the interaction between ICV effects of CRF and CNS noradrenaline depletion
Bakke, H. K., Bogsnes, A., & Murison, R. C. C. (1990) · Physiology & Behavior · doi:10.1016/0031-9384(90)90379-i · Cited by 23
Dorin, R. I., Zlock, D. W., & Kilpatrick, K. A. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90100-x · Cited by 23
Forman, S. D., Bissette, G., Yao, J., Nemeroff, C. B., & van Kammen, D. P. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90083-3 · Cited by 22
Milanick, W. J., Polo‐Parada, L., Dantzler, H. A., & Kline, D. D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12791 · Cited by 21
Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat
Calogero, A. E., Liapi, C. A., & Chrousos, G. P. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346812 · Cited by 21
Self-citationStress-responsive neuromodulators
Gold, P. W. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90172-2 · Cited by 21
Self-citationSchüle, C., Baghai, T. C., & Laakmann, G. (2004) · Neuroendocrinology · doi:10.1159/000076046 · Cited by 21
Cizza, G., Květňanský, R., TARTAGLIA, M. E., Blackman, M. R., Chrousos, G. P., & Gold, P. W. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90674-r · Cited by 21
Self-citationSarnyai, Z., Bíró, É., & Telegdy, G. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90106-4 · Cited by 20
Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls
Roy, A. (1991) · Neuropharmacology · doi:10.1016/s0028-3908(11)80014-6 · Cited by 20
Hypothalamic-Pituitary-Adrenal Axis
Kyrou, I., & Tsigos, C. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_3 · Cited by 20
Weidenfeld, J., Feldman, S., Itzik, A., de Kar, L. D. V., & Newman, M. E. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02641-0 · Cited by 20
Stress, Endocrine Manifestations, and Diseases
Chrousos, G. P., Tsigos, C., & Kyrou, I. (2004) · CRC Press eBooks · doi:10.1201/9781420039702.ch6 · Cited by 19
Self-citationRe-assessing the catecholamine hypothesis of depression: the case of melancholic depression
Gold, P. W., & Wong, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01133-x · Cited by 18
“Valentino has shown that CRH stimulates the locus caeruleus, while we have shown that NE stimulates CRH release [6].”
Self-citationSaphier, D., & Feldman, S. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90180-9 · Cited by 18
β-Adrenergic receptor binding in human and rat hypothalamus
Little, K. Y., Duncan, G. E., Breese, G. R., & Stumpf, W. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90219-p · Cited by 18
Michelson, D. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00210-5 · Cited by 17
Gu, C., Zhao, Z., Zhu, X., Wu, T., Lee, B. H., Jiao, Y., Lee, C. W., Jung, D. H., Yang, C. H., Zhao, R., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/2419183 · Cited by 15
“NE is a secretagogue of CRF [13] and the CeA receives heavy noradrenergic projections from the brainstem [14].”
BackgroundEffect of Cortisol on Muscle Sympathetic Nerve Activity in Pima Indians and Caucasians
de Courten, B. V., Weyer, C., Snitker, S., Gautier, J., Cizza, G., Chrousos, G. P., Ravussin, É., & Tataranni, P. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021818 · Cited by 15
Self-citationCentral neuroregulation of hypothalamic corticotrolin — releasing hormone (CRH-41) secretion
Tsagarakis, S., & Grossman, A. B. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349619 · Cited by 15
Zeng, J., Kitayama, I. T., Yoshizato, H., Zhang, K., & Okazaki, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00417-x · Cited by 15
Nadaoka, I., Yasue, M., Kitagawa, Y., & Koga, Y. (2012) · Biomedical Research · doi:10.2220/biomedres.33.145 · Cited by 14
“The neurons that release corticotrophin-releasing factor (CRF) project from the lateral paraventricular nuclei (PVN) in the hypothalamus to sympathetic hindbrain regions (47), and, conversely, catecholaminergic fibers from the locus coeruleus (LC)-noradrenergic system project to the PVN (14, 15, 46).”
BackgroundSuárez, M. M., Rivarola, M. A., Molina, S. M., Levin, G. M., Enders, J., & Paglini, P. A. (2004) · Stress · doi:10.1080/10253890400010705 · Cited by 14
“…nucleus of the hypothalamus, which express CRH with its cosecretagogue vasopressin, and other neuropeptides that drive the activity of the sympathetic-adrenal medullary and the hypothalamic–pituitary –adrenal (HPA) systems (Valentino et al., 1983; Calogero et al., 1988; Chrousos, 1992).”
BackgroundEffect of the anesthetic agent propofol on hormonal responses to ECT
Mitchell, P. B., Smythe, G. A., & Torda, T. A. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90659-p · Cited by 14
“Calogero et al. (1988) have also recently shown that noradrenaline stimulates corticotropin-releasing hormone production in an in vitro rat hypothalamic organ culture system.”
BackgroundThe Clinical Implications of Corticotropin-Releasing Hormone
Gold, P. W., Kling, M. A., Whitfield, H. J., Rabin, D. S., Margioris, A. N., Kalogeras, K. T., Demitrack, M. A., Loriaux, D. L., & Chrousos, G. P. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2064-5_38 · Cited by 14
Self-citationAssociation between maternal haemoglobin at 27–29weeks gestation and intrauterine growth restriction
Cordina, M., Bhatti, S., Fernandez, M., Syngelaki, A., Nicolaides, K. H., & Kametas, N. A. (2015) · Pregnancy Hypertension · doi:10.1016/j.preghy.2015.09.005 · Cited by 13
Cayupe, B., Morgan, C., Puentes, G. C., Valladares, L., Burgos, H., Castillo, A., Hernández, A., Constandil, L., Ríos, M., Sáez‐Briones, P., et al. (2021) · Molecules · doi:10.3390/molecules26123568 · Cited by 13
“Brain of prenatally malnourished rats exhibits increased synthesis, release, and noradrenaline turnover [17–26], a neurotransmitter that stimulates CRF transcription in the PVN [27] by activating α1-adrenoceptors [28], and a subsequent increase in cytosolic calcium levels in PVN neurons [29] and CRF secretion [30].”
BackgroundClinical implications of depression in rheumatoid arthritis
Morrow, K., Parker, J. C., & Russell, J. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1790070203 · Cited by 13
4 Role of corticotrophin releasing hormone 41 in depressive illness
Licinio, J., & Gold, P. W. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80096-5 · Cited by 13
Self-citationRouth, V., Hamilton, J. D., Stern, J., & Horwitz, B. A. (1993) · Journal of Nutrition · doi:10.1093/jn/123.1.74 · Cited by 13
Gaillet, S., Malaval, F., Barbanel, G., Pelletier, G., ASSENMACHER, I., & SZAFARCZYK, A. (1991) · Regulatory Peptides · doi:10.1016/0167-0115(91)90060-t · Cited by 13
Inglefield, J. R., Bitran, D., Olschowka, J. A., & Kellogg, C. K. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90227-3 · Cited by 13
Stress Responses and the Pathogenesis of Arthritis
Sternberg, E. M., Chrousos, G. P., Wilder, R. L., & Gold, P. W. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-482490-4.50018-3 · Cited by 13
Self-citationMeasuring hormonal variation in the sympathetic nervous system: catecholamines
Brown, D. E. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511542435.005 · Cited by 12
Tsagarakis, S., REES, L. H., BESSER, G. M., & Grossman, A. B. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00854.x · Cited by 11
β1-Adrenergic mechanism is involved in stress-induced increase in arousal
Shibasaki, T., Yamada, K., Yamauchi, N., Imaki, T., Hotta, M., & Demura, H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90513-4 · Cited by 10
The Mechanisms of Immune Suppression by High-pressure Stress in Mice
Fujiwara, R., Shibata, H., Komori, T., Yokoyama, M., Okazaki, Y., & Ohmori, M. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991777029 · Cited by 10
“Furthermore, the noradrenergic nerve-mediated corticotropin-releasing hormone released from hypothalamic neurons might also be regarded as a possible modulator of stress response (Calogero et al 1988).”
BackgroundLechín, F., & van der Dijs, B. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195326697.003.0005 · Cited by 10
Corticotropin-release inhibitory factor
Engler, D., Liu, J., Clarke, I. J., & Funder, J. W. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)p3202-i · Cited by 9
ORLIAGUET, G. A., Parsadaniantz, S. M., Lenoir, V., Duval, P., & Kerdelhué, B. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420211 · Cited by 9
Brain Injury and Neuroendocrine Function
Eledrisi, M. S., Urban, R. J., & Lieberman, S. A. (2001) · The Endocrinologist · doi:10.1097/00019616-200107000-00005 · Cited by 9
The Neuroendocrinology of Chronic Fatigue Syndrome
Scott, L. V., & Dinan, T. G. (1996) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v02n04_05 · Cited by 9
Psychobiological Substrates of Posttraumatic Stress Disorder?Part I
Keltner, N. L., & Dowben, J. S. (2007) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2007.00117.x · Cited by 8
Réus, G. Z., Manosso, L. M., Arent, C. O., Borba, L. A., & Abelaira, H. M. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1570159x20666220329143804 · Cited by 7
Impact of Childhood Adversity, as Early Life Distress, on Cytokine Alterations in Schizophrenia
Miljević, Č., Munjiza, A., & Jovanović, T. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s396168 · Cited by 9
“For example, acetylcholine (Ach), dopamine (DA), and noradrenaline (NA) promote the secretion of corticotropin-releasing hormone (CRH) in the hypothalamus, while serotonin (5-HT) inhibits the secretion of CRH in the hypothalamus and consequently of adrenocorticotropic releasing hormone (ACTH) in the pituitary gland.(7…”
BackgroundNew Hypotheses to Guide Future Antidepressant Drug Development
Nalepa, I., & Sulser, F. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18500-7_18 · Cited by 7
Višnjevac, N., Mladenović-Segedi, L., Ćurčić, A., Višnjevac, J., & Stajić, D. (2011) · Journal of Medical Biochemistry · doi:10.2478/v10011-011-0019-1 · Cited by 6
“Iron deficiency and fetal anemia lead to incre ased synthesis of corticotropic releasing hormone, causing increased secretion of fetal cortisol, inducing inhibition of fetal growth (21).”
BackgroundStress and corticotropin regulation
Donald, R. A., & Wittert, G. (1994) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199400010-00018 · Cited by 6
Tsumori, C., Shibasaki, T., HOTTA, M., TAKEUCHI, K., Yamauchi, N., Imaki, T., Wakabayashi, I., & Demura, H. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.127 · Cited by 5
Neurohormones in Depression and Anxiety
Altemus, M. M., & Gold, P. W. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-631330-7.50017-4 · Cited by 5
Self-citationdel Bosque‐Plata, L., Amin, M., González‐Ramírez, R., Wu, R., Postolache, T. T., Vergare, M. J., Gordon, D., & Gragnoli, C. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01710-x · Cited by 4
“…CRHR1-mediated comorbidity lies in the central limbic noradrenergic response to CRH, which triggers central NE [65], stimulating adrenal cortisol secretion [66, 67] and—by a positive feedback—hypothalamic and limbic CRH secretion, driving and maintaining the central HPA hyperactivation [68, 69].”
Haas, D. A., Sturtridge, W. C., & George, S. R. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90063-a · Cited by 4
Makhoul, Z. (2007) · UA Campus Repository (The University of Arizona) · Cited by 4
Stress and Endocrine Physiology
Nicolaides, N. C., Pervanidou, P., & Chrousos, G. P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.03751-x · Cited by 4
Self-citationde Carvalho, P. R., Lopes, P. C., & de Almeida, G. F. (2020) · ID on line REVISTA DE PSICOLOGIA · doi:10.14295/idonline.v14i50.2492 · Cited by 3
Shi, M., Liu, C., Qin, Y., Yv, L., & Lu, W. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114468 · Cited by 2
Physiological Responses of Mammals to Overnutrition
Routh, V. H., Stern, J. S., & Horwitz, B. A. (1996) · Comprehensive physiology · doi:10.1002/cphy.cp040262 · Cited by 2
Zangeneh, F. Z., Muhammadnejad, S., Naghizadeh, M. M., Jafarabadi, M. N., Shoushtari, M. S., & Masoumi, M. (2021) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2021.1963221 · Cited by 1
“Clonidine by the stimulatory effect on the alpha2-adrenoceptor can increase the CRH secretion in the organotypic hypothalamus culture (Calogero et al. 1988).”
BackgroundLaboratory Tests to Aid in Psychiatric Diagnosis
Csernansky, J. G., & Posener, J. A. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.405 · Cited by 1
Selective Effects of T-2 Toxin and Ochratoxin a on Immune Functions
Taylor, M. J., Sharma, R. P., & Luster, M. I. (1990) · Springer eBooks · doi:10.1007/978-1-4613-0663-4_45 · Cited by 1
Autonomic response to oral glucose in those with metabolic syndrome
Jindal, R. D. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27750 · Cited by 1
Ghrelin - The Defender of Fat in the Face of Stress: Implications in Obesity Treatment
Patterson, Z. R. (2014) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2014-10055 · Cited by 1
“Neurons in the PVN have been shown to express multiple adrenoreceptor subtypes, such as α1, α1B , α2 and β1-adrenergic receptors (Plotsky, 1987; Calogero et al., 1988; Kiss and Aguilera, 1992; Whitnall et al., 1993; McCune et al., 1993; Pieribone et al., 1994; Day et al., 1997), rendering them…”
BackgroundCorticotropin-Releasing Factor: Central Regulation of Autonomic Nervous and Visceral Function
Fisher, L. A., & Brown, M. R. (1990) · Current topics in neuroendocrinology · doi:10.1007/978-3-642-75837-9_2 · Cited by 1
Neural Regulation of Cytokines
Huston, J. M., & Tracey, K. J. (2008) · Wiley eBooks · doi:10.1002/9783527626151.ch13
Reaction of the Stress-Mediating Endocrine System in Response to Acute Brain Ischemia
Gusev, E. I., & Skvortsova, V. I. (2003) · Springer eBooks · doi:10.1007/978-1-4419-9248-2_12
What is Going on in Psychiatry When Nothing Seems to Happen?
Sfera, A. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00178
Is Side-Stream Smoke a Stressor?
Barbera, N., Iurato, M. P., GEREMIA, E., & Bernardini, R. (1995) · Indoor Environment · doi:10.1177/1420326x9500400305
Феохромоцитома с эктопической продукцией АКТГ: разбор клинических случаев
Marova, E. I., Voronkova, I. А., Лапшина, А. М., Arapova, S., S, K. N., Ya, R. L., Животов, В. А., Gurevich, L. E., & Polyakova, G. A. (2015)
Emack, J. (2012) · TSpace (University of Toronto)
Kuo, S.-C., Yeh, Y., Chen, C. Y., Huang, C. C., Shih, M.-C., Yen, C.-H., Ho, P. S., Liang, C., Tsou, C., Yang, B. Z., et al. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000448
“Moreover, DA promotes the secretion of corticotrophinreleasing hormone (CRH) in the hypothalamus [80], resulting in downstream secretion of cortisol.”
BackgroundAntidepressant-like effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Majumder, I. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Is depression a neuroendocrine disease?
Gold, P. W. (2024) · Brain medicine : · doi:10.61373/bm024v.0106
Self-citationPhysiological Responses of Mammals to Overnutrition
Routh, V. H., Stern, J. S., & Horwitz, B. A. (1994) · Comprehensive physiology · doi:10.1002/j.2040-4603.1994.tb01210.x
Conséquences pharmacologiques et fonctionnelles de l'hétérodimérisation des récepteurs V1B et CRF1
Mion, J. (2013) · theses.fr (ABES) · doi:10.70675/91d47531z8447z44d1z9f7ezf39a8e060318
Metadata
- Authors
- Calogero, A. E., Gallucci, W. T., Chrousos, G. P., & Gold, P. W.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- ORCID
- Calogero, A E
- Venue
- Journal of Clinical Investigation
- Published
- 1988-09-01
- Volume
- 82
- Issue
- 3
- Pages
- 839-846
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303591
- OpenAlex
- W2099891752
- Cited by
- 188
- References
- 66
- Citations by year
- 2024: 3 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 2 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- catecholamines, corticotropin-releasing factor, hypothalamus, norepinephrine, epinephrine, dopamine, alpha1-adrenoceptors, alpha2-adrenoceptors, GABA, phentolamine, prazosin, yohimbine, isoproterenol, serotonin, acetylcholine, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenergic alpha-Agonists, Adrenergic alpha-Antagonists, Adrenergic beta-Agonists, Adrenergic beta-Antagonists, Animals, Catecholamines, Corticotropin-Releasing Hormone, Dopamine, Epinephrine, Hypothalamus, Male, Organ Culture Techniques, Rats, Inbred Strains, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review